Company · CIK 2010788
EXOZYMES INC.
| CIK | 2010788 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | NV |
| Business address | CA |
| Listed | EXOZ (Nasdaq) |
| First annual or quarterly report | 2024-11-12 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292781 | 2026-01-16 | 2026-06-30 | 7 | |
| 333-276987 | 2024-02-09 | 2024-11-12 | 12 |
Filings
20| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-30 | 424B5Shelf takedown | 333-292781 | 0001493152-26-031284 |
| 2026-06-08 | 424B5Shelf takedown | 333-292781 | 0001493152-26-027611 |
| 2026-06-04 | 424B5Shelf takedown | 333-292781 | 0001493152-26-027208 |
| 2026-05-29 | 424B5Shelf takedown | 333-292781 | 0001493152-26-025698 |
| 2026-04-09 | 424B5Shelf takedown | 333-292781 | 0001493152-26-015919 |
| 2026-01-23 | EFFECTDeclared effective | 333-292781 | 9999999995-26-000290 |
| 2026-01-16 | S-3Shelf registered | 333-292781 | 0001493152-26-002547 |
| 2025-12-15 | DRSDraft made public | 377-08810 | 0001493152-25-027713 |
| 2024-11-12 | 424B4Final prospectus | 333-276987 | 0001493152-24-044803 |
| 2024-11-12 | 424B4Final prospectus | 333-276987 | 0001493152-24-044801 |
| 2024-11-08 | EFFECTDeclared effective | 333-276987 | 9999999995-24-003413 |
| 2024-10-21 | S-1/AAmendment | 333-276987 | 0001493152-24-041726 |
| 2024-10-04 | S-1/AAmendment | 333-276987 | 0001493152-24-039580 |
| 2024-09-19 | S-1/AAmendment | 333-276987 | 0001493152-24-037099 |
| 2024-09-06 | S-1/AAmendment | 333-276987 | 0001493152-24-035313 |
| 2024-08-01 | S-1/AAmendment | 333-276987 | 0001493152-24-029826 |
| 2024-05-22 | S-1/AAmendment | 333-276987 | 0001493152-24-021024 |
| 2024-04-17 | S-1/AAmendment | 333-276987 | 0001493152-24-015031 |
| 2024-02-14 | S-1/AAmendment | 333-276987 | 0001493152-24-006408 |
| 2024-02-09 | S-1Registration filed | 333-276987 | 0001493152-24-005725 |